179 related articles for article (PubMed ID: 2297696)
1. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
[TBL] [Abstract][Full Text] [Related]
2. The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity.
Kaplan O; Jaroszewski JW; Clarke R; Fairchild CR; Schoenlein P; Goldenberg S; Gottesman MM; Cohen JS
Cancer Res; 1991 Mar; 51(6):1638-44. PubMed ID: 1998955
[TBL] [Abstract][Full Text] [Related]
3. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies.
Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O
Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.
Lyon RC; Cohen JS; Faustino PJ; Megnin F; Myers CE
Cancer Res; 1988 Feb; 48(4):870-7. PubMed ID: 3338082
[TBL] [Abstract][Full Text] [Related]
5. Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy.
Cohen JS; Lyon RC; Chen C; Faustino PJ; Batist G; Shoemaker M; Rubalcaba E; Cowan KH
Cancer Res; 1986 Aug; 46(8):4087-90. PubMed ID: 3731076
[TBL] [Abstract][Full Text] [Related]
6. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.
Jaroszewski JW; Kaplan O; Cohen JS
Cancer Res; 1990 Nov; 50(21):6936-43. PubMed ID: 2208159
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
[TBL] [Abstract][Full Text] [Related]
8. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
9. 31P and 13C NMR spectroscopic study of wild type and multidrug resistant Ehrlich ascites tumor cells.
Rasmussen J; Hansen LL; Friche E; Jaroszewski JW
Oncol Res; 1993; 5(3):119-26. PubMed ID: 8260748
[TBL] [Abstract][Full Text] [Related]
10. Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells.
Miccadei S; Fanciulli M; Bruno T; Paggi MG; Floridi A
Oncol Res; 1996; 8(1):27-35. PubMed ID: 8704284
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
12. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
Crawford KW; Bowen WD
Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394
[TBL] [Abstract][Full Text] [Related]
13. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
Khaitan D; Chandna S; Dwarakanath SB
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
[TBL] [Abstract][Full Text] [Related]
14. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
Mimnaugh EG; Dusre L; Atwell J; Myers CE
Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
[TBL] [Abstract][Full Text] [Related]
15. Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas.
Evelhoch JL; Keller NA; Corbett TH
Cancer Res; 1987 Jul; 47(13):3396-401. PubMed ID: 3581077
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G
Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations.
Yang CJ; Horton JK; Cowan KH; Schneider E
Cancer Res; 1995 Sep; 55(18):4004-9. PubMed ID: 7664272
[TBL] [Abstract][Full Text] [Related]
18. Two-deoxyglucose as an anti-metabolite in human carcinoma cell line RPMI-2650 and drug-resistant variants.
Keenan J; Liang Y; Clynes M
Anticancer Res; 2004; 24(2A):433-40. PubMed ID: 15152941
[TBL] [Abstract][Full Text] [Related]
19. Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy.
Singer S; Neuringer LJ; Thilly WG; Chen LB
Cancer Res; 1993 Dec; 53(23):5808-14. PubMed ID: 8242640
[TBL] [Abstract][Full Text] [Related]
20. Relationships between cytosolic [ATP], [ATP]/[ADP] and ionic fluxes in the perfused rat heart: A 31P, 23Na and 87Rb NMR study.
Stewart LC; Deslauriers R; Kupriyanov VV
J Mol Cell Cardiol; 1994 Oct; 26(10):1377-92. PubMed ID: 7869398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
